市场调查报告书
商品编码
1413858
自动化配混设备市场:按组件、产品类型、应用和最终用户划分 - 2024-2030 年全球预测Automated Compounding Devices Market by Component (ACD Equipment, ACD Software), Product Type (Intravenous Compounding Systems, Oral Compounding Systems, TPN Compounding Systems), Application, End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年自动配混设备市场规模为23.2亿美元,预计2024年将达25.6亿美元,2030年将达到46.9亿美元,复合年增长率为10.52%。
全球自动配混设备市场
主要市场统计 | |
---|---|
基准年[2023] | 23.2亿美元 |
预测年份 [2024] | 25.6亿美元 |
预测年份 [2030] | 46.9亿美元 |
复合年增长率(%) | 10.52% |
自动配製设备旨在製备用于医疗机构配药的药物。自动化调配设备是将不同剂量的药物混合、稀释、组装过程自动化、高精度、安全的设备。自动化调配设备广泛应用于肿瘤学(化疗药物製备)、全肠外营养(TPN)以及集中製药设施中常见的批量调配等领域。由于需要在无菌环境中有效且安全地製备药物,最终用户主要包括医院药局、复方药局和门诊服务。治疗越来越多的慢性病的药物需求不断增加,以及对个人化医疗的日益关注,正在推动对更多组合药物的需求。此外,提高医疗保健环境中的药品安全标准的重要性日益增加,也推动了自动化配製设备的采用。阻碍自动化混配设备市场成长的是自动化混配系统安装和维护的高成本。需要熟练的专业人员来操作这些复杂的设备,这使得自动化复合设备的实施更加复杂。研究和创新的成长旨在建立可扩展的机械模型,以满足从小型诊所到大型医院的各种业务规模,预计将为市场成长创造机会。此外,投资研究耐用且易于清洗的材料有助于满足严格的卫生和无菌要求。
区域洞察
美洲自动化配料设备市场深受美国和加拿大医疗基础设施和法规环境的影响。除了慢性病增加之外,医疗保健自动化正在推广,以提高配药的准确性和安全性,对自动化配药系统的需求也在增加。在欧盟 (EU),严格的配药监管、注重降低医疗成本以及加强药房和医院的技术实施推动了市场的发展。德国、法国、英国和义大利等国家处于实施这些设备的最前沿,旨在提高医疗保健品质和病人安全。欧盟有兴趣标准化其成员国之间的製药实践,促进自动化配製设备的引进,并促进跨境研究和开发倡议。中国、日本、印度等亚太地区是自动配混设备市场前景看好的成长机会。该地区的市场动态是由医疗基础设施的快速开拓、医疗成本的上升以及对药品安全的日益关注所推动的。
FPNV定位矩阵
FPNV 定位矩阵对于评估自动化配混设备市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对自动化配混设备市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵考察,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1-市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2-市场开拓:我们深入研究利润丰厚的新兴市场,并分析它们在成熟细分市场中的渗透率。
3- 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4-竞争力评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5- 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1-自动配混设备市场的市场规模与预测是多少?
2-在自动化配混设备市场的预测期间内,有哪些产品、细分市场、应用和领域需要考虑投资?
3-自动配混设备市场的技术趋势与法律规范是什么?
4-自动化配混设备市场主要供应商的市场占有率为何?
5-进入自动配混设备市场适合的型态与策略手段有哪些?
[190 Pages Report] The Automated Compounding Devices Market size was estimated at USD 2.32 billion in 2023 and expected to reach USD 2.56 billion in 2024, at a CAGR 10.52% to reach USD 4.69 billion by 2030.
Global Automated Compounding Devices Market
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 2.32 billion |
Estimated Year [2024] | USD 2.56 billion |
Forecast Year [2030] | USD 4.69 billion |
CAGR (%) | 10.52% |
The automated compounding devices are designed to prepare medications for dispensing in healthcare settings. These devices automate the process of mixing, diluting, and assembling drugs in various dosages with a high degree of precision and safety. Automated compounding devices are widely used in several areas such as oncology (for chemotherapy drug preparation), total parenteral nutrition (TPN), and high-volume workloads often found in centralized compounding facilities. The end users primarily include hospital pharmacies, compounding pharmacies, and ambulatory services due to their need for efficient and safe preparation of medications in sterile environments. Increased medication needs to manage rising incidences of chronic diseases, along with the rising focus on personalized medicine, fuels demand for more compounded medications. Additionally, the growing importance of improving pharmacological safety standards in healthcare settings incentivizes the adoption of automated compounding devices. High costs associated with the installation and maintenance of automated compounding systems hamper the growth of the automated compounding devices market. The need for skilled professionals to operate these advanced devices further complicates the implementation of automated compounding devices. Growing research and innovation directed toward creating scalable machine models that cater to varying sizes of operations, from small clinics to large hospitals, are expected to create opportunities for market growth. Furthermore, investing in research for materials that are more durable and easy to clean could aid in meeting stringent hygiene and sterility requirements.
Regional Insights
The market for automated compounding devices in the Americas is highly influenced by the healthcare infrastructure and regulatory environment in the United States and Canada. The increasing prevalence of chronic diseases, coupled with a push towards healthcare automation to enable precision and safety in medication dispensing, fuels the need for automated compounding systems. In the European Union, the market is driven by stringent regulations on medication preparation, a focus on reducing healthcare costs, and increasing adoption of technology in pharmacies and hospitals. Countries such as Germany, France, the UK, and Italy are at the forefront of adopting these devices, aiming to improve the quality of care and patient safety. The EU's interest in standardizing pharmaceutical practices across member states augments the implementation of automated compounding devices and fosters cross-border research and development initiatives. The Asia Pacific region, including countries such as China, Japan, and India, presents a promising growth opportunity for the automated compounding devices market. This region's market dynamics are driven by rapidly developing healthcare infrastructure, increasing healthcare expenditure, and a growing focus on medication safety.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Automated Compounding Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Automated Compounding Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Automated Compounding Devices Market, highlighting leading vendors and their innovative profiles. These include Amerisource Bergen Corporation, ARxIUM Inc., B. Braun SE, Baxter Healthcare Corporation, Becton, Dickinson and Company, Cantel Medical Corp., CapsulCN International Co., Ltd., Codonics Inc., Fagron N.V., ForHealth Technologies, Fresenius Kabi AG, Grifols International S.A., Health Robotics SRL, Loccioni Group, McKesson Corporation, Meditecno S.r.l., Medtronic PLC, Omnicell, Inc., Quirem Medical B.V., ScriptPro LLC, Talyst LLC, Tecan Group Ltd., Terumo Corporation, and Yuyama Co., Ltd..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Automated Compounding Devices Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Automated Compounding Devices Market?
3. What are the technology trends and regulatory frameworks in the Automated Compounding Devices Market?
4. What is the market share of the leading vendors in the Automated Compounding Devices Market?
5. Which modes and strategic moves are suitable for entering the Automated Compounding Devices Market?